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Abstract
SCOPE: The gut microbiota is able to modulate host physiology through the
production of bioactive metabolites. Our recent studies suggest that changes in
gut microbiota composition upon prebiotics supplementation alter tissue levels of
PUFA-derived metabolites in mice. However, in vivo evidence that gut microbes
produces PUFA-derived metabolites is lacking. This study aimed to decipher the
contribution of gut microbes versus that of the host in PUFA-derived metabolite
production. METHODS AND RESULTS: To achieve this goal, we compared
the proportion of PUFA-derived metabolites and the expression of fatty acid
desaturases in germ-free (GF) and conventionalized (CONV) mice fed either a
low fat or Western diet. Higher concentrations of PUFA-derived metabolites were
found in the colonic contents of conventionalized mice (CONV) mice compared
to GF mice. The abundance of these metabolites in host tissues was modulated
by dietary treatments but not by microbial status. Although microbial sta...
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Scope: The gut microbiota is able to modulate host physiology through the production of
bioactive metabolites. Our recent studies suggest that changes in gut microbiota composition
upon prebiotics supplementation alter tissue levels of PUFA-derived metabolites in mice.
However, in vivo evidence that gut microbes produces PUFA-derived metabolites is lacking.
This study aimed to decipher the contribution of gut microbes versus that of the host in
PUFA-derived metabolite production.
Methods and results: To achieve this goal, we compared the proportion of PUFA-derived
metabolites and the expression of fatty acid desaturases in germ-free (GF) and conventional-
ized (CONV) mice fed either a low fat or Western diet. Higher concentrations of PUFA-derived
metabolites were found in the colonic contents of conventionalized mice (CONV) mice com-
pared to GF mice. The abundance of these metabolites in host tissues was modulated by
dietary treatments but not by microbial status. Although microbial status did significantly in-
fluence desaturase expression, no correlations between host enzymes and tissue PUFA-derived
metabolite levels were observed.
Conclusion: Together, these results highlight the ability of the gutmicrobiota to produce PUFA-
derived metabolites from dietary PUFA. However, microbial production of these metabolites
in colonic contents is not necessarily associated with modifications of their concentration in
host tissues.
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1 Introduction
The trillions of bacteria residing in the gastrointestinal tract,
known collectively as the gutmicrobiota, arewell known to in-
fluence host physiology [1]. Interactions between microbiota
and host are, among others, mediated by bacterial production
of active metabolites such as bile acids and short chain fatty
acids [2, 3].
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PUFA-derived metabolites have been associated with
biological properties since feeding conjugated linoleic
acids (CLA) to humans and animals was accompanied by
antiobesogenic, antiatherogenic, antidiabetogenic, and anti-
carcinogenic effects [4–9]. We proposed that PUFA-derived
metabolites could be a new kind of active metabolites
produced by the gut microbes. This hypothesis is supported
by previous studies performed in ruminants indicating
microbes play an important role in PUFA biotransformation.
Rumen microbes are known to biohydrogenate PUFA
such as linoleic acid (LA) and -linolenic acid (-LnA) into
saturated fatty acid (stearic acid, C18:0) [10–12]. Through
these pathways, numerous intermediates are also produced,
including CLA, conjugated linolenic acids (CLnA) as well
as nonconjugated fatty acids such as vaccenic acid (trans-11-
18:1). Other in vitro experiments have shown that bacteria
isolated from human feces are able to synthesize CLA, CLnA,
and vaccenic acid (trans-11-18:1) from LA or -LnA [13–15].
Previous studies using feces, colon, and cecal contents
from germ-free (GF), gnotobiotic, and conventional rodents
indicated that gut microbes were capable of transforming LA
into CLA during in vitro incubations [16, 17]. More recently,
other metabolites derived from the PUFA saturation pathway
were found to be present at higher levels in tissues from
conventional versus GF mice, suggesting that gut microbial
metabolism can affect host fatty acid composition [18].
However, whether gut microbes are required for CLA
accumulation in host tissues remains controversial.
We previously showed that high-fat diet feeding and pre-
biotic supplementation were associated with a modulation
of rumenic acid (CLA cis-9,trans-11-18:2) and vaccenic acid
(trans-11-18:1) proportions in both cecal and subcutaneous
adipose tissues [19, 20]. We also demonstrated that, after an
oral load of PUFA, PUFA-derived metabolite production oc-
curs predominantly in the distal part of the gut (cecum and
colon) where the bacterial population is dense and diverse
[21]. We also showed an accumulation of these PUFA-derived
metabolites locally in the intestinal tissues. Although our pre-
vious results obtained in vivo in mice suggest that the gut mi-
crobiota is able to produce PUFA-derived metabolites, clear
evidence of the implication ofmicrobial production is lacking.
Here, we hypothesized that the gut microbiota is required
for the in vivo production of PUFA-derived metabolites such
as CLA, CLnA, and nonconjugated fatty acids. To investigate
this hypothesis, we performed a comprehensive analysis of
the fatty acid profiles in both the colonic contents and host
tissues of GF and CONV mice fed either a low fat (LFD)
or Western diet (WD). We also evaluated the role of host
enzymes, including desaturases such as stearoyl-CoA desat-
urase 1 (SCD-1) and fatty acid desaturase 3 (FADS3), in mod-
ulating levels of PUFA-derived metabolites in host tissues to
decipher the contribution of gut microbial metabolism ver-
sus host metabolism in modulating tissue fatty acid profiles.
Indeed, recent studies showed that host enzymes could also
modulate CLA profile in host tissues. Vaccenic acid (trans-11-
18:1) could be desaturated into rumenic acid (CLA cis-9,trans-
11-18:2) by a 9-desaturase (called SCD-1) in rodent or hu-
man tissues [22, 23]. In addition to SCD-1, FADS3, another
host desaturase, was characterized last year. This enzyme is
able to transform vaccenic acid (trans-11-18:1) into CLA trans-
11,cis-13-18:2 [24].
2 Materials and methods
2.1 Animals and diets
GF C3H/HeN male mice were bred and reared in flexible
film isolators and maintained under GF conditions with a
14-h light/10-h dark cycle and controlled temperature and
humidity. GF status of the breeding isolators was routinely
checked by analyzing fresh feces using semi-quantitative
PCR for 30 cycles and the universal bacteria primers 8F
(AGAGTTTGATCCTGGCTCAG) and 1391R (GACGGGCG-
GTGWGTRCA) as well as by aerobic and anaerobic culture
on tryptic soy agar plates and Brain Heart Infusion, Wilkins-
Chalgren, and Yeast Mold broths maintained at 37C for 7
days. GF status of the experimental isolator was checked at
least twice, once before the introduction of the experimen-
tal diet and once during the last week of the experiment.
GF C3H/HeN (5.5 week old) mice were conventionalized via
oral gavage with a cecal slurry from C3H/HeN conventional
mice. CONV mice were subsequently housed in individually
ventilated cages. Both CONV and GF mice were housed in
the same animal room, maintained on autoclaved bedding,
and fed the same autoclaved water and diet (LabDiets JL Rat
and Mouse/Auto 6F 5K67, St. Louis, MO, USA) during the
period preceding introduction of experimental diets. Experi-
mental diets were introduced 9 days after conventionalization
of C3H/HeN mice (eight mice/group) and fed for 8 weeks.
All animal procedures were conducted with the approval of
theUniversity of Nebraska-Lincoln Institutional Animal Care
and Use Committee.
Experimental diets were prepared by Research Diets (New
Brunswick, NJ, USA) and sterilized by -irradiation (min 50
kGy, Neutron Products, Dickerson, MD, USA). We used a
customized Western diet (45% kcal from fat and 17% kcal
from sucrose with low maltodextrine/high starch compared
to the D12451 formulation from Research Diets), as these
mice were part of another experiment investigating the im-
pact of various starches on metabolic syndrome that will
be published elsewhere (Bindels L.B., Walter J., Ramer-Tait
A.E.). Composition of the experimental diets is presented
in detail in Supporting Information Table 1 and the fatty
acid profile analyzed by gas chromatography with flame
ionization detector is presented in Supporting Information
Table 2.
2.2 Tissue samples
Mice were euthanized using carbon dioxide. At necropsy,
livers, subcutaneous adipose tissues (SAT), colon tissues, and
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colon contents were weighed and immediately flash frozen
in liquid nitrogen. A piece of SAT was also fixed in RNA
later (Ambion, Life Technologies, Grand Island, NY, USA).
All samples were stored at −80C until use.
2.3 Fatty acid profile analysis
To determine the fatty acid profile in colonic contents, colon
tissues, and SAT, we utilized 25 mg of colonic contents,
30 mg of colon tissues, or 20 mg of SAT [21]. Colonic
contents, colon tissues, and SAT were homogenized in a
methanol:chloroform mixture (1:2 V/V). Homogenates were
filtered with Whatman filters N1 (porosity 10 m). Fil-
ters were rinsed with 2 ml of chloroform and 1 ml of
methanol. Homogenates were purified successively with KCl
0.88% and KCl 0.88%:methanol (1:1 V/V). After centrifuga-
tion (1500 × g, 5 min), the chloroform phase was collected in
new tubes and evaporated under a nitrogen flux.
The esterified fatty acids were then subjected to an alka-
line hydrolysis (saponification). Briefly, a solution of KOH
in methanol was added and incubated at 70C for 1 h. The
free fatty acids were methylated by adding 0.4 ml of HCl in
methanol (1.2 M) and incubating at 70C for 20 min. FAME
(fatty acid methyl esters) were then extracted with hexane.
Quantification of FAME was made by gas-liquid chro-
matography (Focus GC, Thermo-Finnigan, Interscience, Bel-
gium). The chromatograph was equipped with a flame ion-
ization detector and a 100 m capillary column (id 0.25 mm,
film thickness 0.20 m; RT-2560, Restek, Interscience, Bel-
gium) using H2 as the carrier gas at a constant flow of 1.5
mL/min. Oven temperature was initially set at 80C, in-
creased by 25C/min to 175C (held for 10 min), then in-
creased by 1C/min to 200C (held for 15 min), and then
increased again by 5C/min to 215C (held for 5 min) before
being decreased by 20C/min to 80C. The flame ionization
detector temperature was maintained at 250C. The identifi-
cation of each peak was made by comparing retention times
with pure FAME standards (Larodan Fine Chemicals AB,
Malmo¨, Sweden).
In accordance with an approach commonly used in the lit-
erature, PUFA and PUFA-derivedmetabolites in colonic con-
tent and host tissues were presented as percentages of iden-
tified fatty acids (Figs. 1–3). However, we obtained similar
results when PUFA and PUFA-derived metabolites were ex-
pressed in absolute amounts (milligrams of fatty acid/grams
of content or tissues) (Supporting Information Tables 3–5).
2.4 Real-time quantitative PCR
Total RNA was extracted using the TriPure isolation reagent
(Roche Diagnostics Belgium, Vilvoorde, Belgium) according
to manufacturer’s instructions, with an additional step for
the SAT (samples were heated at 60C for 5 min after homog-
enization in Tripure). RNA quality was checked for a sub-
set of samples using an Agilent 2100 Bioanalyzer (Agilent
Technologies, Santa Clara, CA, USA). cDNA was prepared
via reverse transcription of 1 g of total RNA using the Kit
Reverse transcription System (Promega, Leiden, The Nether-
lands). For the liver, real-time PCR was performed with the
SetpOnePlusTM real-time PCR system and software (Applied
Biosystems, Den Ijssel, The Netherlands) using SYBR-Green
(Mesa Fast qPCRTM, Eurogentec, Seraing, Belgium) for detec-
tion. For the SAT, real-time PCR was performed with an Ep-
pendorffMastercycler ep realplex using SYBRGreen (5Prime
RealMasterMix SYBR ROX, Gaithersburg, MD, USA) for de-
tection. Ribosomal protein L4 (RPL4) was chosen as house-
keeping gene to normalize the data, which was analyzed
according to the 2−CT method [25]. Primer sequences for
the targeted mouse genes are RPL4 F: CAAGAAGACCAAG-
GAGGCTGT; RPL4 R: GGTTTCTCATTTTGCCCTTG; SCD-
1 F: CCTCTTCGGGATTTTCTACTACATG; SCD-1 R: GC-
CGTGCCTTGTAAGTTCTGT; FADS3 F: TGCTGTGGGCT-
GCCAGTT; FADS3 R: CACCCTGACAGCAACGAAGA.
2.5 Fecal microbiota analysis
Fecal microbiota composition was analyzed by 16S rRNA
gene sequencing of fecal samples in the context of an inde-
pendent project dedicated to the investigation of the impact
of various starches on metabolic syndrome that will be pub-
lished elsewhere (Bindels LB, Walter J, Ramer-Tait AE).
Genomic DNA was extracted from feces using a QIAamp
DNA Stool Mini Kit (Qiagen, Valencia, CA, USA) according
to the manufacturer’s instructions, including a bead beating
step in lysozyme-based buffer. Briefly, the V5-V6 region
of the 16S rRNA gene was PCR-enriched, with further
tailing. Amplicons were purified, quantified, and sequenced
using an Illumina Miseq (v3 kit) to produce 2 × 300 bp
sequencing products. Initial quality filtering of the reads
was performed with the Illumina Software. Quality scores
were visualized with the FastQC software (http://www.bio
informatics.babraham.ac.uk/publications.html), and reads
were trimmed to 250 bp (R1) and 230 bp (R2) with the
FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/).
Next, reads were merged with the merge-illumina-pairs
application (with p-value = 0.02, enforced Q30 check, perfect
matching to primers which are removed by the software,
and otherwise default settings including no ambiguous
nucleotides allowed) [26]. For samples with >20 000 merged
reads, a subset of 20 000 reads was randomly selected
using Mothur 1.32.1 centos 5.5 for Linux [27] to avoid large
disparities in the number of sequences. Putative chimeras
were identified against the Gold reference database and
removed using the UPARSE pipeline implemented in
USEARCH v7.0.1001 [28]. For this study, we focused our
analysis on CLA-producing bacteria previously identified
during in vitro studies described in the literature [13–15].
Bioinformatics searches (BLAST) for bacteria known to
produce PUFA-derived metabolites were performed on
the dataset in order to analyze the impact of the WD
on the number of CLA-producing bacteria. Results were
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Figure 1. Profiles of PUFA and PUFA-derived metabolites (CLA and non-conjugated metabolites) in colonic contents of GF and CONV mice
fed a low fat or Western diet. Results are expressed as a percentage of identified fatty acids. Data are presented as the mean ± SEM. Mean
values with different letters are significantly different from one another (p < 0.05) as determined by Tukey’s post hoc ANOVA statistical
analysis.
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Figure 2. Profiles of PUFA and PUFA-derived metabolites (CLA and nonconjugated metabolites) in colon tissues of GF and CONV mice fed
a low fat or Western diet. Results are expressed as a percentage of identified fatty acids. Data are presented as the mean ± SEM. Mean
values with different letters are significantly different from one another (p < 0.05) as determined by Tukey’s post hoc ANOVA statistical
analysis.
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Figure 3. Profiles of PUFA and PUFA-derived metabolites (CLA and nonconjugated metabolites) in the subcutaneous adipose tissue (SAT)
of GF and CONV mice fed a low fat or Western diet. Results are expressed as a percentage of identified fatty acids. Data are presented as
the mean ± SEM. Mean values with different letters are significantly different from one another (p < 0.05) as determined by Tukey’s post
hoc ANOVA statistical analysis.
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expressed in percent proportions based on the total number
of sequences in each sample. Full protocol and accession
numbers are provided in Supporting Information materials
and methods.
2.6 Statistical analysis
Data are presented as the mean ± SEM. Statistical signifi-
cance of difference between groups was assessed by one-way
analysis of variance (ANOVA) followed by post hoc Tukey’s
multiple comparison test (GraphPad Prism Software, San
Diego, CA, USA). p < 0.05 was considered as statistically
significant. Mean values with different letters are signifi-
cantly different from one another (p < 0.05) as determined
by Tukey’s post hoc ANOVA statistical analysis. Regarding
the analysis of gut microbiota composition performed only
in CONV mice, statistical significance of difference between
the two groups was assessed by Student’s t-test (GraphPad
Prism Software).
3 Results
3.1 Synthesis of PUFA-derived metabolites
in colonic contents is influenced by both
microbial metabolism and diet
Neither microbial status of the mice (GF versus CONV) nor
dietary treatment (LFD versus WD) altered PUFA (LA and -
LnA) proportions in colonic contents (Fig. 1A and B). Despite
no difference in PUFA proportions, we did, however, observe
a clear difference between levels of PUFA-derived metabo-
lites present in GF and CONV mice when all were fed an
LFD. Specifically, proportions of CLA cis-9,trans-11-18:2, CLA
trans-11,trans-13-18:2, and CLA trans-9,trans-11-18:2 were all
significantly higher in CONV mice compared to GF mice
(Fig. 1C, E, and F). Although not significant, the abundance
of CLA trans-10,cis-12-18:2 also tended to be higher in CONV
mice compared toGFmice (Fig. 1D). Levels of nonconjugated
metabolites (trans-10-18:1 and trans-11-18:1) were also signif-
icantly increased in CONV mice compared to GF mice when
all were fed an LFD (Fig. 1G and H). WD feeding did not
change PUFA (LA and -LnA) or PUFA-derived metabolite
proportions in colonic contents of GFmice (Fig. 1). However,
WD feeding did decrease the proportions of PUFA-derived
metabolites present in the colonic contents of CONV mice
(Fig. 1C–H) even though WD feeding did not modify PUFA
proportions (Fig. 1A and B).
3.2 Levels of PUFA-derived metabolites in host
tissues are influenced by diet but not by
microbial metabolism
WD feeding of both GF and CONV mice significantly in-
creased the presence of LA in colonic tissues (Fig. 2A).
However, tissue abundance of -LnA was not modified by
microbial status of the mice (GF or CONV) or by dietary
treatment (LFD or WD) (Fig. 2B). In colonic tissues, pro-
portions of the two major CLA isomers, rumenic acid (CLA
cis-9,trans-11-18:2), and CLA trans-10,cis-12-18:2, were found
to be similar among all treatments (Fig. 2C and D), as were
proportions of the minor CLA isomers trans-11,trans-13-18:2
and trans-9,trans-11-18:2 between GF and CONVmice fed the
same diet (Fig. 2E and F). However, their proportions were
decreased in both GF and CONV mice fed a WD as com-
pared to an LFD (Fig. 2E and F). Levels of nonconjugated
PUFA metabolites were not influenced by the microbial sta-
tus of the mice (Fig. 2G and H). However, the proportion of
trans-10-18:1 was significantly increased in CONVmice fed a
WD (Fig. 2G). Although not significant, similar trends were
also observed for vaccenic acid levels in the colon tissues of
both GF and CONV mice fed a WD (Fig. 2H).
An evaluation of the fatty acid profile in subcutaneous adi-
pose tissue (SAT) revealed that LA levels were significantly in-
creased byWD feeding of both GF and CONVmice (Fig. 3A).
An opposite effect was observed for the proportion of -LnA,
which was significantly decreased by WD feeding both in GF
and CONV mice (Fig. 3B). Rumenic acid (CLA cis-9,trans-11-
18:2) proportionswere significantly increased byWD feeding,
but were not influenced by the microbial status of the mice
(Fig. 3C). WD feeding decreased proportions of the CLA iso-
mers trans-11,trans-13-18:2 and trans-9,trans-11-18:2 in both
GF and CONV mice (Fig. 3E and F), a phenomenon consis-
tent with that observed in colonic tissues. Of note, CLA trans-
11,trans-13-18:2was the only PUFA-derivedmetabolitewhose
tissue levels were regulated by microbial status (Fig. 3E).
Abundance of the nonconjugated PUFA derivative trans-
10-18:1 was increased by WD feeding of both GF and CONV
mice (Fig. 3G). WD feeding had no effect on vaccenic acid
(trans-11-18:1) levels in GF or CONV mice compared to LFD
feeding (Fig. 3H). However, the proportion of vaccenic acid
(trans-11-18:1) tended to be higher in CONV mice compared
to GF mice when both were fed a LFD (Fig. 3H).
3.3 Both microbial status and dietary treatment
influence desaturase mRNA expression
and desaturation ratios
Given the discrepancy between host tissues and colonic con-
tents regarding the abundance of PUFA-derived metabolites,
we sought to determine if changes in host enzymes could ex-
plain our findings. To that end, we estimated the activity and
analyzed the mRNA expression of SCD-1, a 9-desaturase
known to desaturate vaccenic acid (trans-11-18:1) into ru-
menic acid (CLA cis-9,trans-11-18:2), and FADS3, another
host desaturase recently described to transform vaccenic acid
(trans-11-18:1) into CLA trans-11,cis-13-18:2 [24].
An estimation of SCD-1 activity was performed by cal-
culating the ratio between the product (cis-9-16:1) and the
substrate (16:0) of this enzyme, known as the “desaturation
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Figure 4. SCD-1 desaturation ratios (cis-9-16:1/16:0) for colon tissue, liver, and subcutaneous adipose tissue (SAT) of GF and CONV mice
fed a low fat or Western diet. Data are presented as the mean ± SEM. Mean values with different letters are significantly different from one
another (p < 0.05) as determined by Tukey’s post hoc ANOVA statistical analysis.
ratio”. No significant differences were observed among the
various treatments for the cis-9-16:1/16:0 ratios in colon tis-
sues (Fig. 4A). In both the liver and SAT, WD feeding de-
creased the cis-9-16:1/16:0 ratios (Fig. 4B and C). In the SAT,
this ratio was significantly higher in GF mice compared to
CONV mice when both were fed an LFD; however, this dif-
ference disappeared when a WD was fed (Fig. 4C). Microbial
status did not have an impact on hepatic cis-9-16:1/16:0 ra-
tios (Fig. 4B). No differences in the cis-9-18:1/18:0 ratios were
observed in the colons, livers, or SAT of mice from any treat-
ment (data not shown).
Given the significant changes observed in the hepatic and
SAT desaturation ratios, we sought to analyze desaturase
mRNA expression in these tissues. No significant differences
in FADS3 mRNA expression were observed between GF and
CONV mice or between LFD and WD fed mice in either tis-
sue (Fig. 5A and B). In the SAT, WD feeding significantly
decreased SCD-1 mRNA expression in both GF and CONV
mice compared to LFD feeding; these alterations were in-
dependent of microbial status (Fig. 5D). Feeding a WD sig-
nificantly decreased hepatic SCD-1 expression in GF mice
but not in CONV mice (Fig. 5C). Of note, hepatic SCD-1
mRNA expression was 1.8-fold higher in GF mice compared
to CONV mice when an LFD was fed, but that increase was
not statistically significant (p = 0.08, Student’s t-test).
3.4 Western diet feeding altered the abundance of
the bacteria known to produce PUFA-derived
metabolites
Given our observations of decreased PUFA derivatives in
CONV mice fed a WD, we performed a next-generation
sequencing analysis of the fecal microbiota to determine
changes in abundance of CLA-producing bacteria. Our anal-
ysis revealed that feeding a WD to CONV mice significantly
decreased abundance of Lachnospiraceae family members as
well as the speciesRoseburia intestinalis (Table 1).WD feeding
also tended to decrease numbers of Roseburia hominis (Table
1). Members of the Bifidobacterium genus were undetectable
in our analysis.
4 Discussion
Previous studies have suggested that the gut microbiota is ca-
pable of producing PUFA-derived metabolites in vivo. How-
ever, studies documenting the unequivocal contribution of
gut microbial metabolism to the synthesis of PUFA-derived
metabolites were lacking. By comparing the levels of PUFA-
derived metabolites (mainly CLA and nonconjugated fatty
acids) present in GF and CONV mice fed either a LFD or a
WD, we present clear evidence that the gut microbiota is re-
quired for the synthesis of dietary PUFA-derived metabolites
in colonic contents.
For most of the FA considered as bacterial PUFA-
derived metabolites (vaccenic acid; trans-10-18:1; rumenic
acid; CLA trans-11,trans-13-18:2; CLA trans-9,trans-11-18:2),
we observed a considerable increase of their abundance in
CONV compared to GFmice when a LFDwas fed. The higher
levels of PUFA-derived metabolites in the colonic contents of
CONV mice compared to GF mice highlight the major con-
tribution of the gut microbiota to PUFA metabolite propor-
tions found in colonic contents. The presence of some PUFA-
derived metabolites in the colonic contents of GF mice (i.e.,
cis-9,trans-11-18:2; trans-10,cis-12-18:2 or trans-11-18:1) must
be interpreted as a consequence of their presence in the diets.
In colonic contents, WD feeding of CONVmice was asso-
ciated with decreased proportions of PUFA-derived metabo-
lites as compared to the LFD fedmice. This decrease inPUFA-
derived metabolites could be due to a shift in gut microbiota
composition and/or activity induced by the WD. Indeed, WD
feeding significantly decreased the fecal abundance of the
Lachnospiraceae family members and the species Roseburia
intestinalis, two bacterial taxa known for their in vitro produc-
tion of PUFA-derived metabolites.
In a previous study where mice were force-fed veg-
etable oils, we observed that the fatty acid profiles found in
intestinal tissues were in accordance with those observed
in intestinal contents [21]. However, in the present long-
term study, analysis of the PUFA-derived metabolites re-
vealed discrepancies between colonic contents and host tis-
sues (colon, SAT). Specifically, proportions of most PUFA-
derived metabolites found in the colon tissue were similar
C© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
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Figure 5. SCD-1 and FADS3 mRNA expression in
liver and subcutaneous adipose tissue (SAT) of
GF and CONV mice fed a low fat or Western diet.
Data are presented as the mean ± SEM. Mean
values with different letters are significantly dif-
ferent from one another (p < 0.05) as determined
by Tukey’s post hoc ANOVA statistical analysis.
Table 1. Bioinformatics analysis using BLAST searches for bacte-
ria known to produce PUFA-derived metabolites
LFD WD
Lachnospiraceae family 51.59 ± 1.46 46.04 ± 1.91*
Lactobacillus genus 0.009 ± 0.0045 0.024 ± 0.0073
Roseburia intestinalis 9.71 ± 1.32 2.43 ± 0.94***
Roseburia hominis 2.26 ± 0.50 1.68 ± 0.35
CONV mice were fed either a low fat or a Western diet. Data
are expressed as relative abundance (%) normalized to the total
number of sequences and presented as the mean ± SEM.
*p < 0.05; ***p < 0.001 as determined by a Student’s t-test.
between GF and CONV mice whereas the levels of these
metabolites were higher in the colonic content of CONVmice
compared to GF mice.
Previous studies analyzing the accumulation of CLA pro-
duced by gut microbes in host tissue provided conflicting
results [16–18]. One study reported no difference in CLA ac-
cumulation in host tissue between GF and gnotobiotic rats
whereas another study reported that LA supplementation led
to an increased CLA content in host tissues of conventional
rats but not in GF rats [16, 17]. Altogether, our results lead
us to propose that in this study, the bacterial production of
PUFA-derivedmetabolites does not influence host tissue fatty
acid profiles. However, Kishino et al. have shown that higher
levels of metabolites derived from PUFA saturation pathway
are found in tissues of conventional but not GF mice, sug-
gesting that gut microbe metabolism is able to modulate host
fatty acid composition [18]. Furthermore, we showed in a pre-
vious study, that upon prebiotic supplementation, production
of PUFA-derived metabolites was increased and able to mod-
ulate fatty acid profile in intestinal tissue and SAT [19, 20].
Therefore, as only a few subset of bacteria are able to produce
these PUFA-derived metabolites [13–15], we propose that the
contribution of the gut microbial metabolism to tissue fatty
acid profile could only become significant upon stimulation
of these bacteria (with prebiotics for instance). It is also tempt-
ing to speculate that the FA profile found in colon tissues is
merely influenced by the FA profile present in the diet. How-
ever, in the colon tissues of both GF and CONVmice, we ob-
served higher proportions of the CLA isomers trans-11,trans-
13-18:2 and trans-9,trans-11-18:2 in LFD-fed mice compared
to WD-fed mice. These results suggest that tissue levels of
these two minor isomers are not directly related to their con-
centrations in the diets, as they were present in higher quan-
tity in the WD compared to the LFD.
In view of these observations, we hypothesize that host
metabolism influences the proportion of CLA isomers found
not only in colon tissue, but also in liver and SAT, and
that some lipid moieties classically attributed to bacte-
rial metabolism are also synthesized in host tissues from
precursors present in the diet. Indeed, host enzymes, mainly
desaturases, can produce CLA from vaccenic acid (MUFA;
trans-11-18:1). Specifically, the host enzymes SCD-1 and
FADS3 are able to introduce a double bond in vaccenic acid
[22–24]; SCD-1 introduces a double bond in the 9 position
whereas FADS3 introduces a double bond in the 13 posi-
tion, leading to the formation of CLA cis-9,trans-11-18:2 and
CLA trans-11,cis-13-18:2, respectively [22–24].
To assess the role of SCD-1 in the modulation of tissue
PUFA-derived metabolite profiles, we estimated SCD-1 activ-
ity by calculating “desaturation ratios” in colon, liver, and
adipose tissues. Desaturation ratios describe the ratio be-
tween the MUFA produced by SCD-1 (palmitoleic acid and
oleic acid) and the corresponding saturated fatty acid used
C© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.mnf-journal.com
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by SCD-1 (stearic acid and palmitic acid) [29, 30]. The cis-9-
16:1/16:0 ratio was decreased by WD feeding independent of
the microbial status of the mice both in the liver and in the
SAT. Given the modulation of desaturation ratios in the liver
and SAT, we then measured the mRNA expression of SCD-1
and FADS3 in these tissues. FADS3 mRNA expression in
the liver and SAT was not influenced by microbial status or
dietary treatment. This finding indicates that modulation of
FADS3 expression was not involved in the changes of PUFA-
derived metabolite proportions observed in the SAT (mainly
CLA isomers trans-11,trans-13-18:2 and trans-9,trans-11-18:2).
However,mRNA expression of FADS3 has been shown to not
correlate with its translation rate [31]. Future studies assess-
ing FADS3 protein expression and enzymatic activity may
provide additional insight into the relationship between this
enzyme and the changes observed in PUFA-derived metabo-
lites in host tissues. Hepatic SCD-1 mRNA expression was
decreased by WD feeding in GFmice but not in CONVmice.
In the SAT, SCD-1 mRNA expression was decreased by WD
feeding in both GF and CONV mice. This observation could
be linked to elevated dietary levels of MUFA and PUFA since
it was reported that PUFA decrease SCD-1 expression [32,33].
In conclusion, this study provides clear evidence of the
contribution of the gut microbial metabolism in PUFA-
derivedmetabolite synthesis and abundance of thesemetabo-
lites in colonic content. However, themicrobial production of
thesemetabolites in colonic contents is not necessarily associ-
ated withmodifications of their concentration in host tissues.
In fact, some CLA and CLnAmetabolites are produced by the
actions of specific enzymes expressed in liver or adipose tis-
sues on trans fatty acids or CLA/CLnA found in fatty diets that
can be absorbed mostly in the jejunum. Further exploration
of host metabolism related to the oxidation/storage of those
“novel” fatty acids would therefore be of great interest.
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